Sökresultat

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. “This digital test, which patients perform on their own with minimal involvement from healthcare personnel, improves the primary care physician's ability to determine who should be further examined by blood tests for Alzheimer's pathology ear

https://www.multipark.lu.se/article/new-digital-cognitive-test-diagnosing-alzheimers-disease - 2026-05-19

What if brain diseases could be cured by turning on the proper genes? Meet our scientist, Professor Cecilia Lundberg! She explains how gene therapy may complement cell therapies to combat Parkinson’s disease. Cecilia Lundberg is head of the CNS Gene Therapy Research Group and has spent her whole career developing cutting-edge tools that may be used in future therapies to slow down or cure neurodeg

https://www.multipark.lu.se/article/meet-our-scientists-podcast-cecilia-lundberg-about-gene-workshop - 2026-05-19

Have you ever wondered what the journey of someone living with Parkinson’s disease looks like? Meet our scientist, Professor Per Odin! He shares his experiences of the bumpy road faced by patients he has supported over the years, both in healthcare and in research studies. Parkinson’s disease is a long, challenging course; one that science works tirelessly to understand, where halting neurodegener

https://www.multipark.lu.se/article/meet-our-scientists-podcast-odin-about-parkinsons-journey - 2026-05-19

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.multipark.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-05-19

With an approval rate of just 17 %, this year’s Swedish Research Council grants were harder than usual to secure. Still, several of MultiPark’s group leaders were awarded major grants in Medicine and Health 2025. Receiving grants from the Swedish Research Council is seen as a mark of quality and an important step in advancing an independent research group. Recently, six MultiPark researchers were

https://www.multipark.lu.se/article/multipark-scientists-awarded-prestigious-vr-consolidator-grant - 2026-05-19

Nine researchers from MultiPark have been listed as Highly Cited Researchers by Clarivate, highlighting their significant global research impact. Clarivate acknowledges researchers whose publications rank among the top 1% most cited in their fields over the past eleven years. The selected scientists have published several highly-cited papers. Congratulations to Oskar Hansson, Shorena Janelidze, Sa

https://www.multipark.lu.se/article/multipark-researchers-recognized-clarivates-highly-cited-list - 2026-05-19

Recently, MultiPark opened its doors to the local Parkinson’s Association, who were invited behind the scenes to see how research on their condition is conducted. Here are some of the laboratories that were visited. Today’s basic research on brain disorders such as Parkinson’s may be the starting point for tomorrow’s treatments. This may explain the participants’ deep interest in MultiPark’s exper

https://www.multipark.lu.se/article/journey-discovery-research-multipark-opens-labs-parkinsons-association - 2026-05-19

The Promobilia Foundation is investing SEK 25 million in a new large-scale research project targeting Parkinson’s disease. The donation enables four research groups—one at Lund University and three at Karolinska Institutet—to join forces in developing new treatment strategies that address the root causes of the disease. Using innovative approaches, including advanced gene therapies and targeted ve

https://www.multipark.lu.se/article/promobilia-foundation-invests-sek-25-million-new-large-scale-research-project-targeting-parkinsons - 2026-05-19

Almost half of all dementia cases may be associated with modifiable factors such as smoking and high blood pressure. At the same time, some risk factors are built into our biology, such as age, sex, and genetics. But dementia is not a single disease, rather symptom of multiple underlying disorders. Therefore, risk factor profiles for various dementia subtypes are likely to vary. A new study highli

https://www.multipark.lu.se/article/how-lifestyle-and-biology-shape-brain-changes-linked-dementia - 2026-05-19

Turning scientific knowledge into solutions that improve people’s lives is the ultimate goal of research. But the path from novel scientific data to an innovation that may impact health care is long; many promising ideas never get a fair chance. For 16 years, MultiPark Innovation has supported researchers in their first efforts in transforming discoveries into inventions that may benefit patients

https://www.multipark.lu.se/article/multipark-innovation-grants-have-generated-inventions-2011 - 2026-05-19

Modern technology is helping our researchers to get a sneak peek into the brain – and now the winning image has been chosen in MultiPark’s photo competition #Neurovision. All entries will be on display for the public at MultiPark Café’s exhibition – come and explore the secrets of the brain with us on 3 March! MultiPark is a strategic research area at Lund University, where interdisciplinary resea

https://www.multipark.lu.se/article/multiparks-vernissage-neurovision-celebrating-winners-our-photo-competitions - 2026-05-19

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading d

https://www.multipark.lu.se/article/new-blood-marker-reduces-risk-false-diagnosis-alzheimers-disease - 2026-05-19

The symptom profiles of different neurodegenerative diseases often overlap, and diagnosing age-related cognitive symptoms is complex. A patient may have multiple overlapping disease processes in the brain at the same time. Now, researchers at Lund University have developed an AI model showing that it is possible to detect several neurodegenerative diseases from a single blood sample. The study is

https://www.multipark.lu.se/article/new-ai-model-can-detect-multiple-cognitive-brain-diseases-single-blood-sample - 2026-05-19

Simpler diagnosis using a smell test, mapping brain circuits behind symptoms linked to Parkinson’s, and significant funding for advanced gene therapies. And a recently completed clinical trial with promising results for stem cell-based transplantation in Parkinson’s patients. These are five examples from the strategic research area MultiPark over the past year. MultiPark conducts multidisciplinary

https://www.multipark.lu.se/article/world-parkinsons-day-five-multipark-projects-could-improve-diagnosis-understanding-and-future - 2026-05-19

The 2026 Jeffrey L. Morby Prize has been awarded to researchers from Lund University and Washington University for a study published in Nature Medicine. The paper describes a blood test capable of detecting changes in the brain associated with Alzheimer’s disease. Oskar Hansson, Professor of Neurology, and Gemma Salvadó, Research Associate – both at Lund University – are co-authors of the article:

https://www.multipark.lu.se/article/drop-blood-can-detect-alzheimers-international-award - 2026-05-19

A team of international researchers led by senior lecturer Åsa Mackenzie at Lund University has received a $9 million USD grant from the Aligning Science Across Parkinson’s (ASAP) initiative, in partnership with The Michael J Fox Foundation for Parkinson’s Research (MJFF), to advance understanding of Parkinson’s disease treatment, with a particular focus on depression, anxiety, and other psychiatr

https://www.multipark.lu.se/article/exceptional-success-multipark-researchers-highly-competitive-international-call-parkinsons-research - 2026-05-19

This article is over 5 years old, and the information may therefore be outdated. How do you stop Alzheimer’s disease without a simple way to diagnose it? It’s a real chicken and egg problem, as I wrote last year on TGN. Discovering a treatment for Alzheimer’s requires lots of clinical trials for new drugs—but it’s difficult to enroll participants without a way to identify people who have the disea

https://www.multipark.lu.se/article/unexpected-way-we-might-one-day-diagnose-alzheimers - 2026-05-19

This article is over 5 years old, and the information may therefore be outdated. A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein (NFL) in blood samples from patients with Alzheimer’s disease. Recently published in JAMA Neurology, the study suggests that the NFL concentration

https://www.multipark.lu.se/article/more-evidence-blood-tests-can-detect-risk-alzheimers - 2026-05-19

This article is over 5 years old, and the information may therefore be outdated. In recent years, it has become increasingly clear to researchers that the protein galectin-3 is involved in inflammatory diseases in the brain. A study led by researchers at Lund University in Sweden now shows the de facto key role played by the protein in Alzheimer’s disease. When the researchers shut off the gene th

https://www.multipark.lu.se/article/researchers-block-protein-plays-key-role-alzheimers-disease - 2026-05-19

This article is over 5 years old, and the information may therefore be outdated. Daniella was awarded the prize for "successful effort as a young researcher and group leader". Link to Jeanssons Foundation website (in Swedish)

https://www.multipark.lu.se/article/daniella-ottosson-receives-prize-jeanssons-foundation - 2026-05-19